649
Views
21
CrossRef citations to date
0
Altmetric
Review

Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016–2020)

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 877-892 | Received 24 Jan 2021, Accepted 27 Apr 2021, Published online: 16 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Xueqin Huang, Li You, Eugenie Nepovimova, Miroslav Psotka, David Malinak, Marian Valko, Ladislav Sivak, Jan Korabecny, Zbynek Heger, Vojtech Adam, Qinghua Wu & Kamil Kuca. (2023) Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK). Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Jingyu Zhu, Xintong Li, Huiqin Meng, Lei Jia, Lei Xu, Yanfei Cai, Yun Chen, Jian Jin, Li Yu & Mingzhu Gao. (2023) Molecular modeling strategy for detailing the primary mechanism of action of copanlisib to PI3K: combined ligand-based and target-based approach. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Ruikai Wang, Amin Li, Jiachang Liu, Ming Fang, Yan Zhu, Juan Huang, Yinjie Liu, Long Huo & Qinghai You. (2023) BEZ235 reduction of cisplatin resistance on wild-type EGFR non-small cell lung cancer cells. Journal of Chemotherapy 35:2, pages 95-103.
Read now

Articles from other publishers (18)

Guang Huang, Tomasz Cierpicki & Jolanta Grembecka. (2023) 2-Aminobenzothiazoles in anticancer drug design and discovery. Bioorganic Chemistry 135, pages 106477.
Crossref
Abdalrahim M. Ali, Alaa A. Makki, Walaa Ibraheem, Mohammed Abdelrahman, Wadah Osman, Asmaa E. Sherif, Ahmed Ashour, Sabrin R. M. Ibrahim, Kholoud F. Ghazawi, Waad A. Samman & Abdulrahim A. Alzain. (2023) Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles. Molecules 28:5, pages 2289.
Crossref
Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, Reham Kharmah & Sanaa Bardaweel. (2023) Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases. Viruses 15:2, pages 568.
Crossref
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, Maria Sinicropi & Alessia Catalano. (2023) Targeting Breast Cancer: An Overlook on Current Strategies. International Journal of Molecular Sciences 24:4, pages 3643.
Crossref
Maria Antonietta Occhiuzzi, Gernando Lico, Giuseppina Ioele, Michele De Luca, Antonio Garofalo & Fedora Grande. (2023) Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents. European Journal of Medicinal Chemistry 246, pages 114971.
Crossref
Jindi Huang, Liye Chen, Jiangxia Wu, Daiqiao Ai, Ji-Quan Zhang, Tie-Gen Chen & Ling Wang. (2022) Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions. Journal of Medicinal Chemistry 65:24, pages 16033-16061.
Crossref
Yingmin Jiang, Wendian Xiong, Lei Jia, Lei Xu, Yanfei Cai, Yun Chen, Jian Jin, Mingzhu Gao & Jingyu Zhu. (2022) Developing a Naïve Bayesian Classification Model with PI3Kγ structural features for virtual screening against PI3Kγ: Combining molecular docking and pharmacophore based on multiple PI3Kγ conformations. European Journal of Medicinal Chemistry 244, pages 114824.
Crossref
Ahmed A. Al-Qahtani, Ioanna Pantazi, Fatimah S. Alhamlan, Hani Alothaid, Sabine Matou-Nasri, George Sourvinos, Eleni Vergadi & Christos Tsatsanis. (2022) SARS-CoV-2 modulates inflammatory responses of alveolar epithelial type II cells via PI3K/AKT pathway. Frontiers in Immunology 13.
Crossref
Yunhao Ma, Yanan Tian, Zhongkun Zhou, Shude Chen, Kangjia Du, Hao Zhang, Xinrong Jiang, Juan Lu, Yuqing Niu, Lixue Tu, Jie Wang, Huanxiang Liu, Hongmei Zhu, Peng Chen & Yingqian Liu. (2022) Design, Synthesis and Biological Evaluation of Neocryptolepine Derivatives as Potential Anti-Gastric Cancer Agents. International Journal of Molecular Sciences 23:19, pages 11924.
Crossref
Wendian Xiong, Lei Jia, Junjie Liang, Yanfei Cai, Yun Chen, Yunjuan Nie, Jian Jin & Jingyu Zhu. (2022) Investigation into the anti-airway inflammatory role of the PI3Kγ inhibitor JN-PK1: An in vitro and in vivo study. International Immunopharmacology 111, pages 109102.
Crossref
Maria V. Zapevalova, Ekaterina S. Shchegravina, Irina P. Fonareva, Diana I. Salnikova, Danila V. Sorokin, Alexander M. Scherbakov, Alexander A. Maleev, Stanislav K. Ignatov, Ivan D. Grishin, Alexander N. Kuimov, Maryia V. Konovalova, Elena V. Svirshchevskaya & Alexey Yu. Fedorov. (2022) Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway. International Journal of Molecular Sciences 23:18, pages 10854.
Crossref
H. Jemmy Christy, Swetha Vasudevan, S. Sudha, Mahmoud Kandeel, Kumaran Subramanian, S. R. Pugazhvendan, P. Ronald Ross & Velmurugan. (2022) Targeting Streptomyces-Derived Streptenol Derivatives against Gynecological Cancer Target PIK3CA: An In Silico Approach. BioMed Research International 2022, pages 1-15.
Crossref
Bexultan Kazybay, Qinglei Sun, Kanat Dukenbayev, Ayan Amantaiuly Nurkesh, Na Xu, Aidana Kutzhanova, Madina Razbekova, Anar Kabylda, Qing Yang, Qian Wang, Cuiping Ma & Yingqiu Xie. (2022) Network Pharmacology with Experimental Investigation of the Mechanisms of Rhizoma Polygonati against Prostate Cancer with Additional Herbzymatic Activity . ACS Omega 7:17, pages 14465-14477.
Crossref
Bing Yang, Bo Zhang, Qun Zhao, Jin Li & Yujun Shi. (2022) Development of New Thiophene-Containing Triaryl Pyrazoline Derivatives as PI3Kγ Inhibitors. Molecules 27:8, pages 2404.
Crossref
Maria Sofia Basile, Eugenio Cavalli, James McCubrey, Jorge Hernández-Bello, José Francisco Muñoz-Valle, Paolo Fagone & Ferdinando Nicoletti. (2022) The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19. Drug Discovery Today 27:3, pages 848-856.
Crossref
A. E. Sinotsko, A. V. Bespalov, N. V. Pashchevskaya, V. V. Dotsenko, N. A. Aksenov & I. V. Aksenova. (2021) N,N′-Diphenyldithiomalonodiamide: Structural Features, Acidic Properties, and In Silico Estimation of Biological Activity. Russian Journal of General Chemistry 91:11, pages 2136-2150.
Crossref
Divya Jain, Yogesh Murti, Wasi Ullah Khan, Rajib Hossain, Mohammad Nabil Hossain, Krishn Kumar Agrawal, Rana Azeem Ashraf, Muhammad Torequl Islam, Pracheta Janmeda, Yasaman Taheri, Mohammed M. Alshehri, Sevgi Durna Daştan, Balakyz Yeskaliyeva, Aliya Kipchakbayeva, Javad Sharifi-Rad & William C. Cho. (2021) Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2021, pages 1-31.
Crossref
Chiara Borsari, Martina De Pascale & Matthias P. Wymann. (2021) Chemical and Structural Strategies to Selectively Target mTOR Kinase. ChemMedChem 16:18, pages 2744-2759.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.